The remarkable success of the vaccine for a killer virus: Hepatitis B
Carla S. Coffin – 10 April 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17‐beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms
Christian A. Hudert, Leon A. Adams, Anna Alisi, Quentin M. Anstee, Annalisa Crudele, Laura G. Draijer, EU‐PNAFLD investigators, Samuel Furse, Jan G. Hengstler, Benjamin Jenkins, Kylie Karnebeek, Deirdre A. Kelly, Bart G. Koot, Albert Koulman, David Meierhofer, Phillip E. Melton, Trevor A. Mori, Stuart G. Snowden, Indra Mourik, Anita Vreugdenhil, Susanna Wiegand, Jake P.
P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
- Read more about P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
Yahui Zhu, Li Gu, Xi Lin, Xinyi Zhou, Bingjun Lu, Cheng Liu, Yajun Li, Edward V. Prochownik, Michael Karin, Fubing Wang, Youjun Li – 9 April 2022
Risk of cardiovascular disease and loss in life expectancy in NAFLD
Ying Shang, Patrik Nasr, Linnea Widman, Hannes Hagström – 9 April 2022
A standardized immunosuppressive regimen for patients who received liver transplantations treated with atezolizumab–bevacizumab to avoid graft rejection?
Edouard Larrey, Filomena Conti, Manon Allaire – 8 April 2022
Reply
Vlad Ratziu – 8 April 2022
Operational tolerance is not always permanent: A 10‐year prospective study in pediatric liver transplantation recipients
Laura J. Wozniak, Robert S. Venick, Bita V. Naini, Jason Scapa, Michelle J. Hickey, Maura Rossetti, Yael Korin, Elaine F. Reed, Douglas G. Farmer, Ronald W. Busuttil, Jorge H. Vargas, Sue V. McDiarmid – 7 April 2022 – Immunosuppression withdrawal can be safely performed in select liver transplantation recipients, but the long‐term outcomes and sustainability of tolerance have not been well studied.
Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Marta Alonso‐Peña, Ricardo Espinosa‐Escudero, Elisa Herraez, Oscar Briz, Maria Luisa Cagigal, Jesus M. Gonzalez‐Santiago, Aida Ortega‐Alonso, Conrado Fernandez‐Rodriguez, Luis Bujanda, Marta Calvo Sanchez, Delia D´Avola, Maria‐Carlota Londoño, Moises Diago, Jose C. Fernandez‐Checa, Carmen Garcia‐Ruiz, Raul J. Andrade, Frank Lammert, Jesus Prieto, Javier Crespo, Javier Juamperez, Alvaro Diaz‐Gonzalez, Maria J. Monte, Jose J. G. Marin – 7 April 2022
Letter to the editor: Regression of liver fibrosis after bariatric operations: A glass two‐third full rather than half empty
François Pattou, Guillaume Lasailly, Violeta Raverdy, Robert Caiazzo, Philippe Mathurin – 7 April 2022
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation
Kawthar A. Mohamed, Marwan Ghabril, Archita Desai, Eric Orman, Kavish R. Patidar, John Holden, Susan Rawl, Naga Chalasani, Chandra Shekhar Kubal, Lauren Nephew – 6 April 2022 – Liver transplantation (LT) is the final step in a complex care cascade. Little is known about how race, gender, rural versus urban residence, or neighborhood socioeconomic indicators impact a patient's likelihood of LT waitlisting or risk of death during LT evaluation. We performed a retrospective cohort study of adults referred for LT to the Indiana University Academic Medical Center from 2011 to 2018.